In order to discern to what degree the current therapeutic standard of care addresses MPS VI phenotypes, we directly compared galsulfase ERT in ArsbCOIN/COIN mice with restoration of Arsb to the WT state. Here, ARSB is linked to mucopolysaccharidosis type 6.